Investing in the Future of Therapeutics
At Applied Biologics, our mission has always been to advance human health. Building on our legacy in regenerative medicine and biologic innovation, we are expanding that mission through Applied Biologics Venture Capital — our new investment arm dedicated to supporting the next generation of breakthrough biotechnology companies.
What We Invest In
Applied Biologics Venture Capital focuses on early- and growth-stage biotechnology companies developing next-generation therapeutic solutions, including:
- Regenerative medicine & cellular therapies
- Novel biologics
- Advanced drug-delivery platforms
- Gene and molecular therapeutics
- Immunomodulatory & anti-inflammatory technologies
- Enabling tools and platforms that advance therapeutic discovery
Our Vision
We believe the future of medicine will be shaped by bold ideas, transformative science, and the entrepreneurs who are willing to pursue them. Our venture division exists to champion these innovators, accelerate life-changing therapies, and foster a healthier world through strategic investment and hands-on partnership.
What We Seek
We look for companies with strong scientific foundations, differentiated pipelines, and the potential to create significant clinical and commercial impact.
More Than Capital
Our portfolio companies gain more than funding — they gain the experience, insight, and support of a team deeply rooted in biotech innovation. We provide:
Strategic Guidance
Strategic guidance grounded in decades of scientific and clinical expertise
Broad Network
Access to a broad network of industry leaders, researchers, and clinical partners
Operational Support
Operational support for regulatory, manufacturing, and commercialization pathways
Long-term Alignment
Long-term alignment focused on impactful, sustainable growth
Let’s build what’s next — together.
Applied Biologics Venture Capital is actively seeking visionary founders and emerging biotech leaders who are pushing the boundaries of therapeutic innovation. If you are building a company that can shape the future of medicine, we want to hear from you.